Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has remained flat, although notably Lin BioScience gained 18%. The past year has been better, since the industry has gained 15% in that time. As for the next few years, earnings are expected to grow by 70% per annum.
Has the Taiwanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 24 Jan 2025 | NT$545.4b | NT$24.8b | -NT$10,902,841,000.00 | 34.9x | -50x | 22x |
Sun, 22 Dec 2024 | NT$490.1b | NT$24.8b | -NT$10,848,531,000.00 | 32.6x | -45.2x | 19.8x |
Tue, 19 Nov 2024 | NT$510.0b | NT$24.9b | -NT$10,463,953,000.00 | 37.5x | -48.7x | 20.5x |
Thu, 17 Oct 2024 | NT$527.3b | NT$23.5b | -NT$10,829,095,000.00 | 35.8x | -48.7x | 22.5x |
Sat, 14 Sep 2024 | NT$557.8b | NT$23.5b | -NT$10,829,095,000.00 | 32.9x | -51.5x | 23.8x |
Mon, 12 Aug 2024 | NT$552.7b | NT$22.1b | -NT$11,296,958,000.00 | 33.6x | -48.9x | 25x |
Wed, 10 Jul 2024 | NT$550.7b | NT$21.9b | -NT$11,110,643,000.00 | 43.2x | -49.6x | 25.1x |
Fri, 07 Jun 2024 | NT$508.0b | NT$21.9b | -NT$11,110,643,000.00 | 41.7x | -45.7x | 23.2x |
Sun, 05 May 2024 | NT$455.6b | NT$21.6b | -NT$12,502,137,000.00 | 48.2x | -36.4x | 21.1x |
Tue, 02 Apr 2024 | NT$445.5b | NT$20.9b | -NT$10,667,106,000.00 | 52.1x | -41.8x | 21.3x |
Thu, 29 Feb 2024 | NT$451.6b | NT$20.7b | -NT$9,591,454,000.00 | 39.4x | -47.1x | 21.8x |
Sat, 27 Jan 2024 | NT$433.7b | NT$19.9b | -NT$9,830,596,000.00 | 39.8x | -44.1x | 21.8x |
Mon, 25 Dec 2023 | NT$467.1b | NT$19.9b | -NT$9,737,975,000.00 | 43.1x | -48x | 23.5x |
Wed, 22 Nov 2023 | NT$475.5b | NT$19.4b | -NT$10,027,536,000.00 | 39x | -47.4x | 24.5x |
Fri, 20 Oct 2023 | NT$449.7b | NT$18.4b | -NT$10,823,013,000.00 | 44.6x | -41.6x | 24.4x |
Sun, 17 Sep 2023 | NT$499.9b | NT$18.3b | -NT$10,776,417,000.00 | 43x | -46.4x | 27.3x |
Tue, 15 Aug 2023 | NT$451.8b | NT$18.9b | -NT$10,207,311,000.00 | 45x | -44.3x | 23.9x |
Thu, 13 Jul 2023 | NT$468.7b | NT$18.7b | -NT$10,725,166,000.00 | 43.6x | -43.7x | 25.1x |
Sat, 10 Jun 2023 | NT$490.9b | NT$17.6b | -NT$11,251,141,000.00 | 43.4x | -43.6x | 27.9x |
Mon, 08 May 2023 | NT$529.2b | NT$18.5b | -NT$9,923,392,000.00 | 45.7x | -53.3x | 28.6x |
Wed, 05 Apr 2023 | NT$499.9b | NT$20.3b | -NT$9,157,006,000.00 | 43.9x | -54.6x | 24.6x |
Fri, 03 Mar 2023 | NT$528.5b | NT$22.3b | -NT$7,093,875,000.00 | 38x | -74.5x | 23.7x |
Sun, 29 Jan 2023 | NT$494.2b | NT$21.8b | -NT$7,778,690,000.00 | 36.2x | -63.5x | 22.7x |
Tue, 27 Dec 2022 | NT$497.1b | NT$21.8b | -NT$7,778,690,000.00 | 36.4x | -63.9x | 22.8x |
Thu, 24 Nov 2022 | NT$527.4b | NT$21.8b | -NT$7,522,211,000.00 | 36.5x | -70.1x | 24.2x |
Sat, 22 Oct 2022 | NT$450.9b | NT$23.1b | -NT$6,633,590,000.00 | 35.1x | -68x | 19.5x |
Mon, 19 Sep 2022 | NT$632.2b | NT$23.1b | -NT$6,633,590,000.00 | 42.6x | -95.3x | 27.4x |
Wed, 17 Aug 2022 | NT$558.2b | NT$23.6b | -NT$5,600,931,000.00 | 30.8x | -99.7x | 23.7x |
Fri, 15 Jul 2022 | NT$513.8b | NT$22.5b | -NT$5,642,821,000.00 | 29.9x | -91.1x | 22.8x |
Sun, 12 Jun 2022 | NT$527.8b | NT$22.5b | -NT$5,642,821,000.00 | 33.2x | -93.5x | 23.4x |
Tue, 10 May 2022 | NT$522.4b | NT$21.7b | -NT$5,726,051,000.00 | 42.2x | -91.2x | 24.1x |
Thu, 07 Apr 2022 | NT$540.8b | NT$21.5b | -NT$5,761,086,000.00 | 30.8x | -93.9x | 25.2x |
Sat, 05 Mar 2022 | NT$516.2b | NT$18.0b | -NT$5,619,404,000.00 | 25x | -91.9x | 28.7x |
Mon, 31 Jan 2022 | NT$433.6b | NT$17.9b | -NT$5,532,702,000.00 | 24.7x | -78.4x | 24.2x |
-78.4x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | 2.11% | |
Healthcare | -0.062% | |
Biotech | -1.19% | |
Biotech | -1.19% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6696 Lin BioScience | NT$152.00 | 15.6% +NT$1.6b | 42.7% | PB4.7x | |
6550 Polaris Group | NT$44.85 | 3.3% +NT$1.1b | -36.6% | PS442.4x | |
6541 Tanvex BioPharma | NT$69.00 | 5.7% +NT$607.1m | 6.3% | PS276.4x | |
6547 Medigen Vaccine Biologics | NT$49.05 | 3.0% +NT$476.7m | -20.1% | PS24.9x | |
6875 Pharmosa Biopharm | NT$56.20 | 6.2% +NT$426.0m | -34.1% | PS143.6x |